Press Release U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
Press Release Nuveen Churchill Direct Lending Corp. Announces Fourth Quarter and Full Year 2023 Results
Press Release Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
Press Release Redwire Opens New Facility in the Washington, DC Region to Support the Company’s Growing Portfolio of National Security Programs
Press Release Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Press Release WisdomTree Board of Directors Sends Letter to Graham Tuckwell in Response to Mr. Tuckwell’s February 20 Letter to the Board
Press Release With a Two-Year Revenue Growth of 411%, Cloud Range Ranked No. 44 on Inc. Magazine’s List of Fastest-Growing Private Companies in the Southeast Region
